81X Stock Overview

An investment holding company, develops, manufactures, and trades in interventional medical devices for cardiovascular and peripheral vascular diseases and disorders worldwide. More details

81X fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	5/6
Past Performance	1/6
Financial Health	6/6
Dividends	0/6

Rewards

Price-To-Earnings ratio (24.3x) is below the Medical Equipment industry average (25.8x)

Earnings are forecast to grow 29.5% per year

Risk Analysis

Highly volatile share price over the past 3 months compared to the German market

Profit margins (19.4%) are lower than last year (28%)

Large one-off items impacting financial results

My Notes

Capture your thoughts, links and company narrative

LifeTech Scientific Corporation Competitors

Eckert & Ziegler

XTRA:EUZ

€927.6m

Drägerwerk KGaA

XTRA:DRW3

€818.5m

Stratec

XTRA:SBS

€362.2m

Carl Zeiss Meditec

XTRA:AFX

€4.0b

Price History & Performance

Summary of share price highs, lows and changes for LifeTech Scientific
Historical stock prices
Current Share Price	HK$0.16
52 Week High	HK$0.29
52 Week Low	HK$0.078
Beta	0.83
1 Month Change	1.90%
3 Month Change	0.63%
1 Year Change	-34.55%
3 Year Change	-58.29%
5 Year Change	n/a
Change since IPO	-58.93%

Recent updates

Shareholder Returns

	81X	DE Medical Equipment	DE Market
7D	0%	-1.6%	0.3%
1Y	-34.6%	-9.1%	6.9%

Return vs Industry: 81X underperformed the German Medical Equipment industry which returned -7.5% over the past year.

Return vs Market: 81X underperformed the German Market which returned 7.2% over the past year.

Price Volatility

Is 81X's price volatile compared to industry and market?
81X volatility
81X Average Weekly Movement	24.3%
Medical Equipment Industry Average Movement	6.4%
Market Average Movement	4.9%
10% most volatile stocks in DE Market	11.8%
10% least volatile stocks in DE Market	2.4%

Stable Share Price: 81X's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: 81X's weekly volatility has increased from 18% to 24% over the past year.

About the Company

Founded	Employees	CEO	Website
1999	1,414	Yuehui Xie	www.lifetechmed.com

LifeTech Scientific Corporation, an investment holding company, develops, manufactures, and trades in interventional medical devices for cardiovascular and peripheral vascular diseases and disorders worldwide. The company operates through Structural Heart Diseases Business, Peripheral Vascular Diseases Business, and Cardiac Pacing and Electrophysiology Business segments. Its products include LAmbre left atrial appendage closure systems, as well as CeraFlex, Cera, HeartR, and Konar-MF VSD occluders; Ankura thoracic aortic aneurysm and abdominal aortic aneurysm stent graft systems; Futhrough endovascular needle systems; delivery systems, such as Fustar steerable and SteerEase introducers; Zoetrack guidewire; Aegisy vena cava filters; Cera vascular plug systems; AcuMark sizing balloons; HearTone implantable cardiac pacing system; and SeQure snare systems, as well as pacemakers.

LifeTech Scientific Corporation Fundamentals Summary

How do LifeTech Scientific's earnings and revenue compare to its market cap?
81X fundamental statistics
Market cap	€796.88m
Earnings (TTM)	€32.75m
Revenue (TTM)	€168.66m

24.3x

P/E Ratio

4.7x

P/S Ratio

Is 81X overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
81X income statement (TTM)
Revenue	CN¥1.28b
Cost of Revenue	CN¥274.29m
Gross Profit	CN¥1.01b
Other Expenses	CN¥757.58m
Earnings	CN¥248.64m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	0.054
Gross Margin	78.58%
Net Profit Margin	19.42%
Debt/Equity Ratio	2.9%

How did 81X perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/30 16:51
End of Day Share Price	2024/12/30 00:00
Earnings	2024/06/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

LifeTech Scientific Corporation is covered by 7 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Wai Chak Yuen	BOCI Research Ltd.
Yuan Gao	China International Capital Corporation Limited
Hanqing Zhu	Guosen Securities Co., Ltd.